Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...
He greets me like an old friend, instantly helping to fade the several nightmare scenarios from my fitful sleep the evening before. He assures me ...
Cottonwood, Arizona exists like a gentle rebellion against everything that makes contemporary life exhausting, tucked away in the Verde Valley where the red rocks frame a community that somehow ...
BURO chats with Diane Chia, Raja Jesrina Arshad, and Sarah Lian on sisterhood, holistic living, and Women’s Wellness Festival ...
Get Q3 2025 insights on Wave Life Sciences: key trial updates, RNA editing advances, financial outlook, and milestones ahead.
INLIGHT is currently ongoing at multiple trial sites, including in the US following clearance of an Investigational New Drug (IND) application. Wave has expanded Cohort 2, Cohort 3, and Cohort 4 (600 ...
WVE-007, an INHBE GalNAc-siRNA for obesity designed to drive fat loss while preserving muscle mass, achieved dose-dependent, mean reductions of Activin E of up to 85% in INLIGHT clinical trial, exceed ...
Remember The Clapper? The plug-in staple may have made for a catchy jingle in the 1980s, but it could also be considered as a ...
The Senate drew closer to a vote on legislation to end the shutdown on Monday after a small group of Senate Democrats broke a ...
Luxe Pack Los Angeles, the West Coast’s premier event for creative, sustainable, and luxury packaging innovation, announced ...
The justices turned away an appeal from Kim Davis, the former Kentucky court clerk who refused to issue marriage licenses to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results